Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli by Catherine Ludden et al.
Correspondence: Mailing address, Discipline of Bacteriology, National University of Ireland Galway, Galway, Ireland. 
Email: c.ludden2@nuigalway.ie 
Received: 23. April.2014, Accepted: 30.May.2014 
Copyright © Journal of Microbiology and Infectious Diseases 2014, All rights reserved
Journal of Microbiology and Infectious Diseases /  2014; 4 (3): 92-96
JMID   doi: 10.5799/ahinjs.02.2014.03.0146
RESEARCH ARTICLE
Molecular epidemiology of extended-spectrum beta-lactamase-producing 
Escherichia coli
Catherine Ludden1, Belinda Hanahoe2, Fiona Boyle1, Benjamin Kanagaratnam1, Martin Cormican1, 
Dearbháile Morris1
1 Antimicrobial Resistance and Microbial Ecology (ARME) Group, School of Medicine, National University of Ireland Galway, 
Galway, Ireland
2 Department of Medical Microbiology, Galway University Hospital, Galway, Ireland.
ABSTRACT
Objectives: E. coli O25b-ST131 has disseminated worldwide in hospitals and the community. The objective of this study 
was to determine the extent to which E. coli O25b-ST131 accounts for extended-spectrum beta-lactamase (ESBL)-
producing E. coli from clinical samples from all sources in this region. 
Methods: Between January and June 2010 ESBL-producing E. coli were collected from 94 routine samples including 47 
from residents of 25 nursing homes, 15 categorized as hospital acquired and 32 others. PCR was performed for detec-
tion of blaCTX-M, blaOXA-1, blaTEM, blaSHV and for the identification of members of the E. coli O25b:ST131 clonal group. PFGE 
was carried out using XbaI in accordance with PulseNet protocols. 
Results: The majority (97%) of isolates harbored a blaCTX-M gene. E. coli O25b-ST131 accounted for 87% of all ESBL-
producing E. coli and for 96% of isolates from nursing home residents. 
Conclusion: The E. coli O25b-ST131 clonal group predominated in the collection of ESBL-producing E. coli, particularly 
in nursing home isolates. J Microbiol Infect Dis 2014; 4(3): 92-96
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Genişlemiş spektrumlu beta-laktamaz üreten E. coli suşlarının moleküler epidemiyolojisi
ÖZET
Amaç: Escherichia coli O25b-ST131 dünyanın her tarafında hastanelerde ve toplumda yaygındır. Bu çalışmanın amacı bu 
bölgedeki farklı kaynaklardan alınan klinik örneklerde genişlemiş spektrumlu beta-laktamaz üreten E. coli suşları arasın-
da E. coli O25b-ST131 yaygınlığını belirlemektir.
Yöntemler: Ocak-Haziran 2010 arasında toplam olarak 25 bakımevinden 47 suş, hastane kaynaklı 15 suş ve diğer kay-
naklardan 32 suş olmak üzere toplam 94 ESBL üreten E. coli suşu klinik örneklerden toplandı. PCR kullanılarak blaCTX-M, 
blaOXA-1, blaTEM, blaSHV ve O25b:ST131 klonal grubu üyeleri tanımlandı. PFGE tiplendirmesi PulseNet protokolüne göre 
XbaI kullanılarak yapıldı. 
Bulgular: Suşların büyük çoğunluğu (% 97) blaCTX-M geni taşımaktaydı. Bütün ESBL üreten E. coli suşlarından % 87’si ve 
bakımevlerinden gelen suşlardan % 96’sı E. coli O25b-ST131 idi. 
Sonuç: E. coli O25b-ST131 klonal grubu bakımevi kaynaklı olanlarda daha belirgin olmak üzere toplanan ESBL üreten E. 
coli suşları arasında baskındı. 
Anahtar kelimeler: Escherichia coli, O25b-ST131, Direnç, Sağlık hizmeti, BakımeviLudden C, et al. E. coli O25b-ST131 predominance in nursing homes. 93
J Microbiol Infect Dis   www.jmidonline.org   Vol 4, No 3, September 2014
INTRODUCTION
The E. coli O25b:ST131 clonal group was first re-
ported in 2008 as a major carrier of CTX-M-15 how-
ever subsequent studies have identified the pres-
ence of this clonal group in earlier isolates dating 
back to 1967.1 Since then it has been reported glob-
ally in both the hospital and community setting and is 
associated primarily with urinary tract infections and 
bacteraemia. Reported risk factors for E. coli O25b-
ST131 include foreign travel, antimicrobial usage, 
catheterisation and admission to a nursing home.2-4 
E. coli O25b-ST131 are often resistant to fluoroqui-
nolones and cephalosporins such as ceftazidime.1 
The  dissemination  of  blaCTX-M-15  is  closely  associ-
ated  with  E. coli O25b-ST131 however blaCTX-M-9, 
blaCTX-M-14 and blaCTX-M-32 have also been observed. 
In addition, a broad range of other antimicrobial re-
sistance genes (blaOXA-1, blaTEM, tetA, aac(6’)-Ib-cr 
and aac(3)-II) primarily carried on transferable IncF 
plasmids are also associated with the group.5
An  increasing  population  of  older  people  re-
sides in nursing homes for extended periods. Nurs-
ing homes are associated with a significant number 
of  antimicrobial-resistant  (AMR)  bacteria  related 
to frequent transfer of patients from hospitals and 
also to factors within the nursing homes including 
the vulnerability of residents, and antimicrobial con-
sumption.6 The relative importance of acquisition of 
AMR bacteria during hospital stay compared with 
dissemination within nursing homes is not well un-
derstood. We have examined the diversity of ex-
tended-spectrum  beta-lactamase  (ESBL)-produc-
ing E. coli isolates from all clinical samples submit-
ted to one laboratory over 6 consecutive months to 
compare isolates from nursing home residents with 
other isolates. 
METHODS
Galway  University  Hospitals  [University  Hospital 
Galway (UHG) and Merlin Park University Hospital 
(MPUH)] and Roscommon County Hospital (RCH) 
account for an approximate combined total of 1,052 
inpatient beds and about 44 000 admissions per 
year. The Clinical Microbiology Laboratory service 
at  UHG  serves  these  hospitals  and  the  nursing 
homes and General Practitioners (GP) throughout 
the  region  serving  a  population  of  approximately 
445 356 (http://www.cso.ie).
Between January 1st and June 30th 2010, ap-
proximately 3 599 clinical isolates of E. coli were 
reported by the Laboratory with urine, blood, wound 
and  respiratory  samples  accounting  for  approxi-
mately 3337, 82, 74 and 66 isolates, respectively. 
All  E. coli  isolates  are  tested  for  susceptibility  to 
cefpodoxime  (Oxoid  Ltd,  UK)  and  cefpodoxime 
non-susceptible isolates were initially assessed for 
ESBL production using cefpodoxime/clavulanic acid 
discs  in  accordance  with  Clinical  Laboratory  Sci-
ence Institute (CLSI) methods and criteria. Ninety 
four  ESBL-producing  E. coli  were  collected  from 
urine (n=80), blood (n=3), sputum (n=9), drainage 
fluid (n=1), and tissue (n=1).
Forty  seven  ESBL-producing  E. coli  isolates 
were from residents of 25 nursing homes (21 pri-
vate and 4 public; NH=47), and 47 were non-nurs-
ing  home  isolates.  Of  the  25  nursing  homes,  18 
were represented by a single isolate, 2 by 2 isolates 
and the remaining five nursing homes by 3 or more 
isolates. The number of beds in each nursing home 
varied from 28 to 62. The nursing home samples 
were submitted in the course of routine investiga-
tion of clinical episodes of suspected infection and 
the interval between admission to the nursing home 
and date of sample collection was not available. Fif-
teen ESBL-producing E. coli were categorized as 
likely hospital associated (HA) on the basis that the 
clinical samples were collected more than 48 hours 
after admission (range 3-79 days). Of the remaining 
32 isolates of ESBL-producing E. coli, 4 were from 
General Practitioners and 28 were from hospital-
ized patients but with samples collected (a) at or 
within 48 hours of admission (n= 16) or (b) submit-
ted from a hospital but with interval from admission 
to sampling not accessible (n=12). For purposes of 
this study these 32 isolates are classified as “oth-
ers”. Thirty of the 32 “others” had previous hospital 
contact (out-patient and in-patient). There was no 
record of nursing home admission for those patients 
hospitalized at time of sampling. 
The E. coli ST131 clonal group was identified 
by PCR specific to the detection of the pabB gene 
(specific  marker  the  E. coli O25b-ST131 clonal 
group) and the trpA gene (to act as a control and 
to ensure quality of DNA).7 All ESBL isolates were 
also tested for blaTEM, blaSHV, blaOXA-1 and blaCTX-M as 
previously described and representative bla genes 
were sequenced using primers specific to the entire 
coding region of blaCTX-M–group 1, blaTEM and blaSHV (Se-
quiserve, Vaterstetten, Germany).8,9 Pulsed field gel 
electrophoresis (PFGE) using XbaI was performed 
by the Pulse-Net protocol with analysis of profiles 
(PFPs) using the Dice coefficient with clustering by 
the  unweighted  pair  group  method  with  arithme-
tic averaging (UPGMA).10 Three major UK ST131 Ludden C, et al. E. coli O25b-ST131 predominance in nursing homes. 94
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variants (Strains A, C and D) were included in the 
PFGE analysis for comparison.5 Chi Square tests 
were applied to compare demographic and clinical 
data from the hospital and nursing homes collec-
tions. 
RESULTS
Table  1  shows  results  for  ST131  status,  blaCTX-M 
genes, blaOXA-1, blaTEM and blaSHV gene detected in 
the 3 categories of isolates. All isolates were con-
firmed  as  carrying  one  or  more  ESBL  encoding 
genes. The ST131 clonal group accounted for 82 
of the 94 isolates with blaCTX-M in 81 of 82 (blaCTX-M-
group1 n=73; blaCTX-M-group 9 n=8) and blaTEM-10 in the re-
maining isolate. Sequencing of a blaCTX-M-group1 gene 
from an ST131 isolate showed blaCTX-M-15 while the 
blaCTX-M-group1 gene in a non ST131 isolate was blaCTX-
M-61. One NH E. coli harbored blaSHV-2, blaCTX-M-group 1, 
blaOXA-1 and blaTEM. A higher percentage of nursing 
home isolates were ST131 (96%) compared with 
hospitals associated (87%) and “other” ESBL-pro-
ducing E. coli (75%) although the differences did not 
reach statistical significance (Table 1). Among the 
12 non-ST131 blaCTX-M was also predominant (n=10) 
with the remaining isolates being blaSHV-2 (n=1) in 
one case and both blaSHV-12 and blaTEM in the other.
Table 1. Characteristics of nursing home, hospital acquired and other ESBL-producing E. coli isolates detected from all 
sample types submitted over a 6 month period. 
Isolate Characteristics Nursing Home, n=47 (%) Hospital, n=15 (%) Others, n=32 (%) Total Isolates, n=94 (%)
ST131 45 (96) 13 (87) 24 (75) 82 (87)
blaCTX-M 47 (100) 15 (100) 29 (91) 91 (97)
blaCTX-M Group 1 42 (89) 12 (80) 26 (81) 80 (85)
blaCTX-M Group 9 5 (11) 3 (20) 3 (9) 11 (12)
blaOXA-1 39 (83) 12 (80) 20 (63) 71 (76)
blaTEM 20 (43) 4 (27) 8 (25) 32 (34)
blaSHV 1 (2) 0 (0) 2 (6) 3 (3)
ST=sequence type; bla=beta-lactamase 
Table 2. Molecular typing of ESBL-producing E. coli and source of isolates.
MLST
Type a PFGE Grouping b Nursing home, n (%) Hospital, n (%) Other n (%) Total, n (%)
ST131 X c 19 (41%) 9 (60%) 17 (53%) 45 (47%)
ST131 Y c 9 (19%) 3 (20%) 1 (3%) 13 (14%)
ST131 Z c 10 (21%) 1 (7%) 2 (6%) 13 (14%)
ST131 Diverse a d 7 (15%) 0 (0%) 4 (13%) 11 (12%)
Non ST131 Diverse ad 2 (4%) 2 (13%) 8 (25%) 12 (13%)
a MLST= Multilocus sequence typing, inferred from PCR specific assay
b PFGE= Pulsed Field Gel Electrophoresis
c X, Y, Z= Represent randomly assigned Pulsed Field Gel Electrophoresis clusters based on based on a similarity of 
> 85%
Diverse ad = Represents isolates not in clusters X, Y and Z based on < 85%
PFGE analysis identified 65 pulsed field pro-
files  (PFPs)  within  the  94  isolates  and  the  refer-
ence Strain A. PFP’s of the E. coli ST131 were > 
78% similar. The ST131 isolates formed 3 clusters 
X to Z, based on a similarity of > 85%. Cluster X 
included  the  pandemic  UK  Strain A  and  45  local 
isolates (NH n=19; OT=17; HA n=9; UK Strain A 
control n=1). Cluster Y comprised mainly nursing 
home isolates (NH n=9, HP n=3; OT=1). Most clus-
ter Z isolates (NH n=10; OT=2; HP n=1) were from 
nursing homes and in particular one nursing home 
provided 7 (54%) of all cluster Z isolates (Table 2). Ludden C, et al. E. coli O25b-ST131 predominance in nursing homes. 95
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The  two  non-ST131  nursing  home  isolates  were 
from residents of the same nursing home and were 
indistinguishable by PFGE, and one of these was 
confirmed by sequencing to harbor blaCTX-M-61. The 
10 non-ST131 isolates from 2 hospital patients and 
8 from the OT category were all quite distinct (61% 
similar) on PFGE and were 58% similar to the group 
of ST131 isolates.
DISCUSSION
The association of AMR with nursing homes is well 
described however the relative importance of dis-
semination within nursing homes compared with ac-
quisition during episodes of care for nursing home 
residents at acute hospitals is not well understood. 
Rooney et al (2009) reported that CTX-M - produc-
ing E. coli O25b-ST131 accounted for 49% of ES-
BL-producing E. coli from nursing homes in North-
ern  Ireland.3  Burke  et  al.  (2012)  reported  E. coli 
O25b-ST131  represented  85%  and  51%  respec-
tively of nursing home and hospital inpatient ESBL-
producing E. coli isolated from Dublin, Ireland.6 E. 
coli O25b-ST131 was reported to account for 21%, 
43% and 41% of ESBL-producing E. coli isolates 
from Japan, South Africa and Canada, respective-
ly.4 In addition, E. coli O25b-ST131 was identified in 
27% of isolates in the United States; however E. coli 
O25b-ST131 was detected in 76% of isolates from 
long-term care facilities in this region of the United 
States.2  Our  data  confirm  other  reports  of  global 
dissemination  of  blaCTX-M-15  carrying  E. coli O25b-
ST131.  Our  study  also  demonstrates  the  striking 
predominance of this clonal group in this region of 
Ireland. Even by comparison with Burke and col-
leagues the predominance we observe (87% of all 
ESBL-producing E. coli) in this collection of consec-
utive clinical isolates from all sources is exception-
ally high. In 2012 ESBL-producing E. coli accounted 
for 8.8% of all E. coli blood stream infections in Ire-
land as a whole. In comparison, ESBL-producing E. 
coli accounted for approximately 21.5% of E. coli 
(20-23%) blood stream infections for most hospitals 
in the West of Ireland where this study was per-
formed (S. Murchan, Health Protection Surveillance 
Centre, personal communication, January 8, 2013). 
It  is  possible  that  there  are  differences  between 
regions of Ireland with respect to case ascertain-
ment related to differences indications for perform-
ing blood cultures and or in laboratory protocols for 
processing blood cultures and susceptibility testing. 
However we are aware of no systematic regional 
bias with respect to any of these factors therefore 
the differences are not readily explained as ascer-
tainment bias. There are also some differences in 
population profile (higher mean age in the region 
with higher proportion of ESBL-producing E. coli) 
though it is not clear that this is sufficient to explain 
the difference.11 It is interesting to speculate if the 
prevalence of a virulent clonal group in this region 
may contribute to the high incidence of ESBL-pro-
ducing E. coli blood stream infection. 
In  conclusion  this  study  demonstrates  that  a 
single clonal group, E. coli O25b-ST131 accounts 
for the vast majority of ESBL-producing E. coli in 
the West of Ireland, with a particular predominance 
(96%) in nursing home isolates. The ST131 variant 
designated as UK strain A represents almost half 
of all ESBL-producing E. coli from all sources. A 
unique aspect of this study is the comparison of the 
homogeneity of ESBL-producing E. coli in consecu-
tive isolates from nursing home and other settings 
in the same region during a defined time period. Al-
though this study is not sufficient to form firm con-
clusions we suggest that there is a trend towards 
greater  homogeneity  of  ESBL-producing  E. coli 
within the nursing home isolates. Given the grow-
ing nursing home population in developed countries 
and the practical challenges of implementing effec-
tive measures to control dissemination of AMR bac-
teria in nursing homes more comprehensive studies 
comparing nursing home isolates with non-nursing 
home isolates are required. 
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